I completely agree. The commercial value of any potential indications from tomorrow’s data is entirely reliant on the company’s ability to communicate and market effectively. I’m not saying that additional functionality in ATL1102 is going to be priced in tomorrow or necessarily ever, I’m just looking to demonstrate potential future pathways for the drug - whether it will be actioned by ANP or otherwise.
ANP Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
